Connor, Clark & Lunn Investment Management (CC&L)
IMMU

Connor, Clark & Lunn Investment Management (CC&L)’s Immunomedics Inc IMMU Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-144,500
Closed -$361K – 961
2016
Q1 		$361K Sell
144,500
-6,900
-5% -$15.5K ﹤0.01% 622
2015
Q4 		$465K Sell
151,400
-4,700
-3% -$13.1K ﹤0.01% 555
2015
Q3 		$268K Buy
156,100
+4,700
+3% +$12K ﹤0.01% 610
2015
Q2 		$615K Sell
151,400
-8,500
-5% -$34.8K 0.01% 400
2015
Q1 		$612K Buy
159,900
+92,900
+139% +$404K 0.01% 373
2014
Q4 		$322K Buy
+67,000
New +$265K ﹤0.01% 452
2013
Q4 		– Sell
-66,300
Closed -$423K – 776
2013
Q3 		$423K Buy
+66,300
New +$382K ﹤0.01% 390

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s IMMU Position: Q2 2016 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Immunomedics Inc (IMMU) in Q2 2016, closing a stake of 144,500 shares — an estimated $361K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IMMU in Q3 2013 and held it in 7 quarters. The position peaked at $615K in Q2 2015. 110 funds tracked by Wall St. Rank hold IMMU as of Q2 2016.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Immunomedics Inc position as of Q2 2016 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 144,500 Immunomedics Inc shares in Q2 2016, an estimated $361K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Immunomedics Inc in Q3 2013 and held it in 7 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Immunomedics Inc position peaked at $615K in Q2 2015.
  • 110 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2016.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2016, filed 15 Aug 2016.